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ATX-LPA1 axis contributes to
proliferation of chondrocytes by
regulating fibronectin assembly
leading to proper cartilage
formation
Tatsuji Nishioka1,*, Naoaki Arima1,*, Kuniyuki Kano1, Kotaro Hama1, Eriko Itai1,
Hiroshi Yukiura1, Ryoji Kise1, Asuka Inoue1,2, Seok-Hyung Kim3, Lilianna Solnica-Krezel4,
Wouter H. Moolenaar5, Jerold Chun6 & Junken Aoki1,7
The lipid mediator lysophosphatidic acid (LPA) signals via six distinct G protein-coupled receptors
to mediate both unique and overlapping biological effects, including cell migration, proliferation
and survival. LPA is produced extracellularly by autotaxin (ATX), a secreted lysophospholipase D,
from lysophosphatidylcholine. ATX-LPA receptor signaling is essential for normal development and
implicated in various (patho)physiological processes, but underlying mechanisms remain incompletely
understood. Through gene targeting approaches in zebrafish and mice, we show here that loss of
ATX-LPA1 signaling leads to disorganization of chondrocytes, causing severe defects in cartilage
formation. Mechanistically, ATX-LPA1 signaling acts by promoting S-phase entry and cell proliferation
of chondrocytes both in vitro and in vivo, at least in part through β1-integrin translocation leading to
fibronectin assembly and further extracellular matrix deposition; this in turn promotes chondrocytematrix adhesion and cell proliferation. Thus, the ATX-LPA1 axis is a key regulator of cartilage formation.
Lysophosphatidic acid (LPA) is produced in the extracellular milieu such as in plasma, mainly by autotaxin
(ATX), and acts on at least six receptors that are specific to LPA (LPA1–6) to exert its functions1,2. Historically,
LPA was identified as a growth factor in serum. Indeed, LPA has been shown to stimulate the proliferation of
many cell types including fibroblasts and cancer cells3,4. Especially, LPA was shown to promote cell cycle entry,
i.e., promote the G0/G1- to S-phase transition4, although different cell types can respond in other ways such as
with cycle exit for neural progenitor cells5. The molecular mechanisms underlying LPA-induced cell cycle progression as well as its in vivo relevance remain unclear. In constitutive LPA receptor knockout (KO) mice, only
LPA1 KO mice showed obvious physical defects, including retardation of physical growth, prominent craniofacial
abnormalities (including a shorter snout) and shorter limbs6,7. ATX is a secreted lysophospholipase D (lysoPLD)
which catalyzes a reaction to produce LPA from lysophosphaditylcholine (LPC)8. ATX KO mice are embryonic
lethal around E9.5–10.5 because of vascular defects9. ATX was originally identified as a cell motility-stimulating
factor secreted by human melanoma cells10,11. Because enhanced expression of ATX has been demonstrated in
various tumor tissues12, ATX may promote proliferation and migration of cancer cells through LPA production.
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Figure 1. Loss of ATX-LPA1 signaling resulted in dyschondroplasia in zebrafish. (a,b) Loss of ATX- LPA1
signaling leads to deformation of the cephalic region in zebrafish embryos. Cephalic regions of wt and lpa1
mutant zebrafish embryos (a) and cephalic regions of zebrafish embryos treated with LPA1 antagonist, LPA1 or
ATX morpholinos (b) at 96 hpf (side view). Cartilage tissues visualized by alcian blue and alizarin red staining
are also shown (ventral view). Scale bar: 100 μm. (c) Both lpa1 and atx are co-expressed with sox9, a marker of
chondrocytes, in zebrafish embryo both at 72 and 96 hpf as judged by in situ hybridization. Scale bar: 50 μm.
(d,e) Loss of ATX-LPA1 signaling in zebrafish embryos leads to mislocalization of chondrocytes in cartilage
tissues. (d) EGFP is expressed specifically in chondrocytes in col2:egfp transgenic zebrafish at 120 hpf. Scale
bar: 100 μm. (e) In zebrafish embryos treated with LPA1 or ATX morpholinos, chondrocytes are unevenly
distributed in Meckel’s and ceratohyal cartilages at 120 hpf. Scale bar: 100 μm.

ATX is also expressed in various normal tissues and is present at high concentration in various biological fluids.
Thus, ATX has an important role in cell proliferation not only in cancer cells but also in various normal cell types.
Here, we show that ATX-LPA-LPA1 signaling promotes the G0/G1-phase to S-phase transition in chondrocytes
by enhancing integrin-dependent fibronectin assembly. These changes contribute to the normal development of
cartilage tissues, based on analyses of both fish and mice.

Results

Loss of ATX-LPA1 signaling results in dyschondroplasia in zebrafish. LPA-related genes are highly

conserved in vertebrates. In zebrafish and mice, the amino acid sequences of ATX and LPA1 are 67 and 85%
identical, respectively. The genes for ATX and the six LPA receptors in vertebrates are completely conserved in
zebrafish13,14. We employed TILLING15 and identified a zebrafish lpa1 mutant with a vu374 mutation at G309 that
results in a premature stop codon (Fig. S1a) in the first extracellular loop of LPA1. Homozygous lpa1 mutants are
able to reach adulthood and are fertile but display a craniofacial malformation: a round-shaped cephalic region
that is also phenocopied in lpa1 mutant mice6 (Fig. 1a).
A search for other mutant and morphant zebrafish with similar phenotypes identified several cases, e.g. the
foxe1 mutant. In most of these cases, cartilage formation was impaired16,17. In addition, lpa1 mRNA was highly
expressed at 72 and 96 hour post fertilization (hpf) in the zebrafish embryos, and the expression pattern overlapped with that of sox9a mRNA (Fig. 1c), a marker of chondrocytes, which shows that chondrocytes express lpa1
in the cartilage. Staining the cartilage of the wild type and lpa1 mutant with alcian blue revealed that the mutant
embryos had disorganized jaw cartilage at both 96 (Fig. 1a) and 120 hpf (data not shown). Both Meckel’s and
ceratohyal cartilages (Fig. S1b), the two main cartilages of the lower jaw, were deformed. The lengths of Meckel’s
and ceratohyal cartilages were shorter in the lpa1 mutants (Fig. 1a and Fig. S1c). Similar abnormalities were
observed when LPA1 was down-regulated either by injection of a morpholino antisense oligonucleotide (MO)
against LPA113 or by treatment with an LPA1 antagonist, Ki16425 (Fig. 1b and Fig. S1d–f), which is known to be
active against zebrafish LPA114.
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Figure 2. Loss of ATX-LPA1 signaling resulted in dyschondroplasia in mice. (a–e) Abnormal skeletal
morphology in skull and limbs in LPA1 KO and ATXflox/− mice. (a) The cephalic regions of wt, LPA1 KO and
ATXflox/− mice (side view) at 3 weeks of age. (b,c) Computed tomographic scanning images of skull and whole
body bones. (d,e) Length of skull bone (d), femur, tibia and humerus (e) in wt, LPA1 KO, ATXflox/+ and ATXflox/−
mice at 3 weeks of age. (Data are mean ±  s.d., n =  8–10, *P < 0.05, **P <  0.01, ***P <  0.001) (f) Loss of ATX-LPA1
signaling leads mislocalization of chondrocytes in mice. Sections of intersphenoid synchondrosis in wt, LPA1
KO and ATXflox/− mice at P0 were stained with H&E or immunostained with anti-Col II antibody. Scale bar:
20 μm and 5 μm in magnified view. (g) The numbers of chondrocyte in intersphenoid synchondrosis per unit
area of wt and LPA1 KO mice at P0, shown by relative ratio (Data are mean ±  s.d., n =  4, **P <  0.01).

ATX is an LPA-producing enzyme that was found to be expressed in the cartilage (Fig. 1c). Knockdown of
ATX with a high dose of ATX MO1 (2.5 ng) was previously shown to induce severe vascular defects14. When a
low dose of ATX MO1 (0.3 ng) or ATX MO2 (3.2 ng) was injected, most of the embryos survived at 120 hpf but
had rounded-shaped heads (Fig. 1b and Fig. S1e), similar to the heads of LPA1 mutant embryos. ATX morphant
embryos also displayed impaired cartilage formation as illustrated by the loss of gill cartilage, i.e. deformation of
Meckel’s and ceratohyal cartilages (Fig. 1b). We conclude that the loss of LPA1 signaling results in dyschondroplasia in zebrafish embryos and that ATX is the main LPA-producing enzyme in cartilage tissues.
To determine how loss of ATX-LPA1 signaling affects the behavior of chondrocytes in cartilage tissues, we
employed col2:EGFP transgenic zebrafish, which expressed EGFP protein specifically in chondrocytes under the
control of the col2a1a promoter18 (Fig. 1d). At 120 hpf, chondrocytes in both Meckel’s and ceratohyal cartilages
maintained their intercalated and stacked organization in control embryos (Fig. 1d). In contrast, uneven sized
and irregularly aligned chondrocytes were observed in LPA1 and ATX MO-injected embryos (Fig. 1e) as well as
LPA1 antagonist (Ki16425)-treated embryos (data not shown).
The cartilage elements of the jaw are largely derived from cranial neural crest cells (CNCCs) that arise from
dorsal and lateral regions of the neural ectoderm at 12 hpf and migrate into the area of the pharyngeal arches at
24–48 hpf, where the cells differentiate into chondrocytes to form the jaw cartilage at 72 hpf17,19. The expression
patterns of slug and sox10, which are markers of CNCCs, were normal in both LPA1 and ATX morphant embryos
(Fig. S1g), and the expression pattern of sox9a was also normal (data not shown). Thus, the migration of CNCCs
and the maturation and differentiation of chondrocytes from CNCCs appeared to be unaffected by the loss of
ATX-LPA1 signaling. It should be noted that bone tissues are not formed in zebrafish embryos until 120 hpf19,
suggesting again that ATX-LPA1 signaling has a critical role in chondrogenesis.

Loss of ATX-LPA1 signaling results in dyschondroplasia in mice.

We next examined the role of
ATX-LPA1 signaling in cartilage formation in mice. LPA1 KO mice showed reduced anteroposterior growth of
skull bone, and shorter femur, tibia and humerus (Fig. 2a–e). We focused on cartilage tissues in the cranial base
Scientific Reports | 6:23433 | DOI: 10.1038/srep23433
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(Fig. S2a) because the base is important for anteroposterior growth of skull bone. In fact, many mutant mice with
defects in the base showed abnormal formation of skull bones like LPA1 KO mice20–22. We found that intersphenoid synchondrosis (the cartilage that links bones at the cranial base) ossified earlier in LPA1 KO mice at 3 weeks
of age (Fig. S2b). At the cellular level, alignment of chondrocytes in the cartilage tissue was disturbed (Fig. 2f) and
the number of cells was also significantly lower in LPA1 KO mice (Fig. 2g). Similar mislocalization of the chondrocytes was observed in other cartilage tissues such in the costa and femur (Fig. S2c).
Since global ATX KO mice are embryonic lethal because of impaired vascular formation9, we set out to produce conditional ATX KO mice. We produced mice with various combinations of ATX wild type, ATX-flox and
null alleles, i.e., ATX+/+, ATX+/flox, ATXflox/flox, ATX+/− and ATXflox/− mice. We found that one flox allele insertion
significantly decreased the serum ATX activity about 15% (Fig. S2d). Interestingly, mice with both ATX-flox and
ATX-null alleles (ATXflox/− mice) showed phenotypes similar to those of LPA1 KO mice. Because ATX+/− mice as
well as mice with other genotypes did not show obvious abnormality at all, it was speculated that the significant
difference between ATX+/− and ATXflox/− (~50% minus ~35%, i.e., ~15%) was important for normal cartilage
formation. Alternatively, it is possible that the insertion of flox allele impairs the transcription or stability of ATX
pre-mRNA in a specific cell type, which affect the normal cartilage formation. From P0 to the adult stage, the
ATXflox/− mice displayed obvious abnormalities in craniofacial morphology and anteroposterior growth of the
skull bone, and shorter femur, tibia and humerus (Fig. 2a–e). The intersphenoid synchondrosis ossified significantly earlier as well in the ATXflox/− mice (Fig. S2b). In addition, at the cellular level, the alignment of chondrocytes was significantly disturbed in ATXflox/− mice (Fig. 2f).
As was observed in zebrafish, loss of ATX-LPA1 signaling did not affect the differentiation of chondrocytes,
since LPA1 KO did not affect the expressions at P0 of type II collagen (Col II), a marker of resting and proliferating chondrocytes or type X collagen (Col X), a marker of pre-hypertrophic and early hypertrophic chondrocytes
(Fig. S2a,e). Taking account of the fact that both LPA1 and ATX were highly expressed in the cartilage tissues in
both zebrafish and mice (Fig. 1c and Fig. S2f), we conclude that ATX-LPA1 signaling functions after chondrocyte
differentiation and that dyschondroplasia is the main defect of LPA1 KO and ATXflox/− mice, and is the cause of
craniofacial abnormalities and retardation of physical growth in these mice.

Inhibition of ATX-LPA1 signaling delays S-phase entry in chondrocytes. To examine the effect
of LPA signaling on cellular functions of chondrocytes, we established primary cultured chondrocytes from
rib cages. We found that proliferation of LPA1−/− chondrocytes was significantly slower than that of LPA1+/+
and LPA1+/− chondrocytes (Fig. 3a). In addition, the cell size of LPA 1−/− chondrocytes was much smaller
(Fig. S3a). We didn’t observe any significant changes in the proliferative activity (Fig. 3a) or cell size (data not
shown) between LPA1+/+ and LPA1+/− chondrocytes. Thus in the following experiments, we used LPA1+/− chondrocytes as a control. Time-lapse images of the proliferating chondrocytes revealed that the doubling time for LPA1−/−
chondrocytes (1660 ±  400 min) was significantly longer than that for LPA1+/− chondrocytes (1280 ±  220 min) (Fig.
S3b and Videos 1 and 2). Although the duration of the M phase did not differ between the two types of chondrocytes (Fig. S3c and Videos 1 and 2), we found that cell cycle progression from the G0/G1 to S-phase as judged by
BrdU incorporation was significantly reduced in LPA1−/− chondrocytes (Fig. 3c,d). Importantly, the smaller cell
size and the reduced proliferative activity were reproduced by adding an LPA1 antagonist (Ki16425) to cultures of
LPA1+/− chondrocytes (Fig. 3b–d, Fig. S3a,b and Video 3) or LPA+/+ chondrocytes (data not shown), indicating
that the phenotypes of LPA1−/− chondrocytes are not due to congenital changes of the chondrocytes. Addition of an
ATX inhibitor (ONO-8430506) also resulted in a smaller cell size (Fig. S3a) and reduced proliferative activity, albeit
to a lesser extent than the LPA1 antagonist (Fig. 3b–d and Video 4). Unlike LPA1−/− chondrocytes or chondrocytes
treated with LPA1 antagonist or ATX inhibitor, chondrocytes from ATXflox/− mice proliferated normally. It should
be mentioned that the culture medium contained significant amounts of ATX and its substrate, lysophosphatidylcholine, both of which are present within fetal calf serum (FCS).
In serum-free medium, LPA significantly stimulated S phase entry of LPA1+/− chondrocytes whereas the effect
was not observed in LPA1−/− chondrocytes or Ki16425-treated LPA1+/− chondrocytes (Fig. 3e,f). In vivo imaging
of LPA1 KO mice at P0 using 5-ethynyl-2′-deoxyuridine (EdU) showed that the proliferation of chondrocytes
in the intersphenoid synchondrosis was significantly decreased (Fig. 3g,h). These in vivo and in vitro findings
indicate that in the absence of LPA1 signaling, the G0/G1-to-S phase transition is prolonged, which explains the
reduction of cell proliferation and decreased cell number of chondrocytes in the intersphenoid synchondrosis
(Fig. 2g and 3g, h).
Integrin-mediated adhesion to fibronectin promotes LPA-induced S-phase entry of chondrocytes. When stimulated by LPA in the presence of EdU, most of the EdU-positive chondrocytes adhered

tightly to the culture plates and spread fully (Fig. 4a), suggesting that the adhesive property of the chondrocytes
affected their proliferation. Since chondrocytes in cartilage tissues are surrounded by and are in contact with
extracellular matrix (ECM), which mainly consists of Col II and fibronectin (FN), we examined the effect of ECM
on LPA-induced cell proliferation. Strikingly, FN coating dramatically enhanced the LPA-induced BrdU incorporation of LPA1+/− chondrocytes (Fig. 4b). The FN effect was not observed in LPA1−/− chondrocytes and was
suppressed by treating the cells with LPA1 antagonist, Ki16425, as well as by treating them with Y27632 and PTX
(Fig. 4b,c), indicating that LPA-induced proliferation on FN-coated plates was LPA1-dependent and mediated via
both the Gα12/13 and Gαi–linked pathways. LPA enhanced the spreading of LPA1+/− but not LPA1−/− chondrocytes
on FN-coated plates (Fig. 4d,e). LPA had similar effects on Col II-coated plates and on non-coated plates (data
not shown) (Fig. 4b and Fig. S4a,b). On both FN- and Col II-coated plates, cell proliferation was suppressed by
GRGDSP, an integrin blocking peptide, but not by a control peptide, GRGESP (Fig. 4f and Fig. S4c), showing an
important role for integrins in LPA-induced chondrocyte proliferation.
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Figure 3. Inhibition of ATX-LPA1 signaling leads delayed S-phase entry in chondrocytes. (a–f) Role of LPA1
signaling in chondrocyte cell proliferation in vitro. (a) Chondrocytes isolated from LPA1+/+ (wt), LPA1+/− (HT)
and LPA1−/− (KO) mice were cultured in medium containing 10% FCS and time-dependent cell proliferation
was determined by cell counting kit-8 (Data are mean ±  s.d., n =  3, N.S.: not significant, **P <  0.01 for day2–5).
(b) HT chondrocytes were cultured as in (a) in the presence of LPA1 antagonist (Ki16425) or ATX inhibitor
(ONO-8430506) (Data are mean ±  s.d., n =  3, ***P <  0.001 for day 5, the significant differences were detected
from day 3 in all comparisons). (c–f) LPA promotes S-phase entry of chondrocytes. After 24 hr starvation,
chondrocytes were stimulated with 10% FCS (c,d) or 10 μM LPA (e,f) and time course dependent incorporation
of BrdU was determined by immunofluorescence using anti-BrdU antibody. For HT chondrocytes, cells were
also cultured in the presence of LPA1 antagonist (Ki16425) or ATX inhibitor (ONO-8430506) (NS: nonstimulated, Data are mean ±  s.d., n =  3 (c,d) or 4 (e,f), N.S.: not significant, ##P <  0.01, **P <  0.01, ***P <  0.001 for
48 hr, the significant differences were detected from 36 hr in all comparisons in d. Scale Bar: 100 μm. (g,h) Role
of LPA1 signaling in chondrocyte cell proliferation in vivo. Cell proliferation of chondrocytes in intersphenoid
synchondrosis of HT and KO mice were evaluated by immunofluorescent images of EdU incorporation (g)
(Scale bar: 50 μm). The numbers of EdU positive chondrocytes in resting zone were also counted and data were
shown as percentage toward total cell numbers (h). (Data are mean ±  s.d., n =  4, **P <  0.01).
Scientific Reports | 6:23433 | DOI: 10.1038/srep23433
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Figure 4. LPA-induced S-phase entry is enhanced by fibronectin and is integrin-dependent in
chondrocytes. (a) Chondrocytes that enter the S-phase as judged by EdU incorporation spread fully. Merged
phase and confocal image of LPA-stimulated HT chondrocytes on cell culture-treated (non-coated) plates 48hr
after stimulation. Nuclei colored in red indicate EdU positive cells. Scale bar: 20 μm. (b,c) LPA-induced S-phase
entry is enhanced by the presence of fibronectin, is LPA1-dependent and is mediated via both Gα12/13 and Gαi
pathways. (b) LPA-induced S-phase entry of HT and KO chondrocytes seeded on non-, Col II- and FN-coated
plates was evaluated by BrdU incorporation assay (NS: non-stimulated, Data are mean ±  s.d., n =  4, N.S.:
not significant, ***P <  0.001, ###P <  0.001, ¶¶¶P <  0.001). (c) Effects of LPA1 signal inhibitors (LPA1 antagonist
(Ki16425), ROCK inhibitor (Y27632) or PTX (Gαi inhibitor)) on LPA-induced S-phase entry in the presence of
fibronectin (NS: non-stimulated, Data are mean ±  s.d., n =  4, ***P <  0.001, ##P <  0.01). (d,e) LPA stimulates cell
spreading via LPA1. (d) Time lapse images of LPA-stimulated HT and KO chondrocytes at 0 and 12 hr after LPA
stimulation on FN-coated plates. Scale bar: 20 μm. (e) HT and KO chondrocytes were stimulated with LPA and
evaluated the cell spreading area 12 hr after the stimulation (NS: non-stimulated, Data are mean ±  s.d., N.S.:
not significant, ***P <  0.001, ###P <  0.001). (f) LPA-induced S-phase entry is integrin-dependent. LPA-induced
S-phase entry of HT chondrocytes was evaluated by BrdU incorporation in the presence of integrin blocking
peptide (GRGDSP) and control peptide (GRGESP) (NS: non-stimulated, Data are mean ±  s.d., n =  4, N.S.: not
significant, ***P <  0.001, ###P <  0.001).

LPA enhances fibronectin assembly through LPA1. FN plays an important role in cell adhesion, which,

in turn, affects the proliferation and survival of many cell types23. In LPA1+/− chondrocytes at 24 hours after
LPA stimulation, FN was distributed in filamentous structures, which overlapped with F-actin and β 1-integrin
(Fig. 5a). In contrast, in LPA1−/− chondrocytes and LPA1+/− chondrocytes treated with Ki16425, Y27632 or
PTX, such filamentous structures were less developed (Fig. 5a). In the presence of LPA, extracellularly added
fluorescently labeled FN (Hilyte-488 FN) was readily incorporated into the filamentous structures and colocalized with F-actin and β 1-integrin in LPA1+/− but not LPA1−/− chondrocytes (Fig. 5b). It thus appears that
FN, once secreted from chondrocytes, is incorporated and assembled into filamentous structures in an LPA1and integrin-dependent manner. Consistent with this notion, LPA-induced FN assembly was prominently suppressed by Ki16425, Y27632 and PTX, and partially inhibited by GRGDSP peptide but not by GRGESP (Fig. 5c).
Importantly, most of the EdU-positive cells showed the filamentous FN structures (Fig. 5d,e). On the basis of
these observations, we hypothesized that LPA stimulates S-phase entry by enhancing FN assembly downstream
of LPA1, through β 1-integrin activation. To further confirm that the interaction of β 1 integrin and FN transmits the intracellular signaling, we examined the formation of focal adhesions which are known to be activated
by the coordinated action of β 1-integrin and FN. We observed that LPA1 signaling promoted focal adhesion
assembly as judged by colocalization of vinculin and actin (Fig. S5). Focal adhesions distributed peripherally
in non-stimulated cells even in LPA1−/− chondrocytes. But, only in LPA1+/− chondrocytes, LPA promoted focal
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Figure 5. LPA enhances formation of fibronectin fibrils through LPA1 leading to S-phase entry of
chondrocytes. (a) LPA enhances formation of fibronectin fibrils through LPA1. HT chondrocytes were
stimulated with LPA in the presence of LPA1 antagonist (Ki16425), ROCK inhibitor (Y27632) or PTX (Gαi
inhibitor). Cells were also immunostained with anti-β 1-integrin antibody and phalloidin. Scale bar: 5 μm.
(b,c) LPA enhances the assembly of extracellularly-added FN into FN fibrils via LPA1, Gα12/13, Gαi and integrinmediated signaling. (b) Intracellular distribution of fluorescent-labeled FN (Hilyte488-FN) added in LPAstimulated chondrocytes. Cells were also immunostained with anti-β 1-integrin antibody and phalloidin. Scale
bar: 5 μm. (c) Chondrocytes were stimulated with LPA in the presence of Hilyte-488 FN and LPA1 antagonist
(Ki16425), ROCK inhibitor (Y27632), PTX (Gαi inhibitor), integrin blocking peptide (GRGDSP) or control
peptide (GRGESP). Scale bar: 5 μm. (d,e) FN distributes in filamentous structures (FN fibrils) in chondrocytes
that undergo LPA-stimulated S-phase entry. (d) HT chondrocytes were stimulated with LPA in the presence of
EdU on Col-II coated plates and were immunostained with anti-FN antibody. Scale bar: 5 μm. (e) Numbers of
EdU-positive cells with or without FN fibrils both in non-stimulated and LPA-stimulated chondrocytes. (Data
are mean ±  s.d., n =  3, N.S.: not significant, ***P <  0.001).
adhesions larger and some of them existed under the cell bodies. and this conformational change was also inhibited by Ki16425, Y27632 and PTX (Fig. S5). These observations confirmed the idea that intracellular signaling via
β 1-integrin was activated downstream of LPA1 signaling.
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Figure 6. ECM formed through LPA1 signaling supports the proliferation of chondrocytes. (a,b) FN
deposition is enhanced by LPA1 signaling. (a) Chondrocytes were cultured in medium containing 10% FCS for
10 days and immunostained with anti-FN antibody. Scale bar: 10 μm. (b) Deoxycholate-insoluble fibronectin in
the extracellular matrix (ECM) was detected by western blot. (c) Comparison of ECM amount between HT and
KO chondrocytes. (d) FN and Col II are similarly expressed in HT and KO chondrocytes. (Data are mean ±  s.d.,
n =  3, N.S.: not significant) (e) ECM formed through LPA1 signaling supports the cell proliferation efficiently.
HT chondrocytes were cultured on the decellularized-ECM plates which formed either by HT chondrocytes
(ECM formed by HT) or KO chondrocytes (ECM formed by KO), and time-dependent cell proliferations were
determined. (Data are mean ±  s.d., n =  3, ***P <  0.001).

ECM formed through LPA1 signaling supports the proliferation of chondrocytes.

To examine
the biological significance of LPA1-mediated FN assembly, we prepared ECM by culturing LPA1+/− and LPA1−/−
chondrocytes. After 10 days of culture, filamentous FN structures were well developed in LPA1+/− chondrocytes
but less developed in LPA1−/− chondrocytes (Fig. 6a). Furthermore, LPA1−/− chondrocytes had significantly less
deoxycholate-insoluble FN protein (Fig. 6b) and significantly less total ECM proteins (Fig. 6c). Under these conditions, both types of chondrocytes showed equal cell numbers per well (Fig. S6a) and FN and Col II mRNA levels
(Fig. 6d), suggesting that deposition of ECM components was attenuated in LPA1−/− chondrocytes. Transmission
electron micrographs of LPA1+/− and LPA1−/− chondrocytes confirmed that thick filamentous bundles were better developed in LPA1+/− chondrocytes than in LPA1−/− chondrocytes (Fig. S6b). We next compared the abilities
of decellularized ECMs (Fig. S6c) formed by LPA1+/− and LPA1−/− chondrocytes to support cell proliferation of
LPA1+/− chondrocytes. After 5 days of culture, ECMs formed by LPA1+/− chondrocytes had significantly more
cells than ECMs formed by LPA1−/− chondrocytes (Fig. 6e). Thus LPA1 signaling regulates the nature of the ECM
and provides the proper external milieu for cell proliferation.

Discussion

LPA1 KO mice show obvious craniofacial abnormalities, retardation of physical growth and a low bone mass6,7.
Previous reports indicated that loss of LPA1 signaling resulted in impaired differentiation of osteoclasts and osteoblasts in vitro7,24,25. However, the fundamental causes of the defects of LPA1 KO mice has remained unclear. In this
study we showed that LPA1 is highly expressed in chondrocytes in both fish (Fig. 1c) and mice (Fig. S2f), and has
a critical role in stimulating the proliferation and positioning of chondrocytes (Fig. 1e and 2f), thereby promoting
proper cartilage formation. Bones, especially long limb bones, are principally formed by a process called endochondral ossification, in which cartilage is replaced by bone and chondrocytes serve as a center of bone growth26.
Because the cartilage phenotype was observed before bone tissues had formed, we conclude dyschondroplasia is
the primary cause of impaired bone development and retarded physical growth of LPA1 KO mice. We also showed
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Figure 7. Diagram of ATX-LPA-LPA1 axis-induced cell proliferation via integrin-dependent fibronectin
assembly in an inside-outside-in manner. In cartilage tissues, LPA produced by ATX activates LPA1 in
chondrocytes (i); LPA1 signaling induces actin stress fiber formation possibly through Gα12/13 and Gαi (ii);
β 1-integrin is translocated along with actin stress fibers (iii); the translocated β 1-integrin then induces
fibronectin assembly (fibronectin fibrils) (iv); fibronectin fibrils promote ECM deposition (v); ECM thus
forms and then supports the proliferation of chondrocytes by promoting cell adhesion (vi). All these processes
contribute to normal cartilage formation.

that ATX is highly expressed in chondrocytes of both zebrafish and mice, and that inactivation of ATX in both
species phenocopied dyschondroplasia as observed when LPA1 was attenuated or deleted. We therefore conclude
that ATX is the major LPA-producing enzyme in cartilage tissues.
The dyschondroplasia of LPA1 KO and ATXflox/− mice can be attributed to dysfunction of chondrocytes.
In vitro experiments revealed that the ATX-LPA1 axis has a pivotal role in chondrocyte proliferation. We also
examined the effect of an ATX inhibitor and LPA1 antagonist on cell proliferation of various cell types and found
that chondrocytes are more sensitive to LPA1 signaling than other cell types (data not shown). The ATX-LPA1
axis promoted cell cycle progression of chondrocytes, in agreement with LPA having growth factor-like activities3,4,27,28 and anti-apoptoc effects as observed in the nervous system5,29,30. Pathophysiological effects of LPA
as a growth factor remain less clear, however it can disrupt normal processes relevant to neurodevelopmental
disorders like hydrocephalus and schizophrenia31,32. To the best of our knowledge, the present study is the first to
demonstrate a physiological meaning for LPA-induced cell proliferation through cell cycle progression.
Our present results raise a new question: how does LPA support the proliferation of chondrocytes downstream of LPA1? Kingsbury et al. reported that LPA-induced cell growth of neural progenitor cells is not due to
increased proliferation but rather to reduced cell death via LPA1/25. However, this is not the case, because we did
not observe any sign of cell death when LPA1 signaling was attenuated (Videos 1–4). These observations also
exclude the possibility that loss of LPA1 signal induced anoikis in chondrocytes. Clues to answering this question are that LPA1−/− chondrocytes were less adhesive to ECM than LPA1+/− chondrocytes (Fig. 4d,e), and that
LPA-induced chondrocyte proliferation was dramatically enhanced by the presence of FN and suppressed by an
integrin-blocking RGD peptide (Fig. 4b,f). These findings suggest that LPA supports chondrocyte proliferation
by upregulating β 1-integrin-mediated cell adhesion to FN. Indeed, mice in which cartilage-specific β 1-integrin
is conditionally knocked out exhibited dyschondroplasia similar to that of LPA1 KO mice33. Furthermore, topical
administration of anti-α5β 1-integrin antibody or RGD-containing peptide to the upper limbs of mouse fetuses
suppressed chondrocyte proliferation and shortened the upper limbs34. Together, these findings indicate that
β 1-integrin and LPA1 have closely related roles in the formation of cartilage.
Another important observation for understanding the mechanism of LPA-induced proliferation is that FN
was assembled to form filamentous structures (Fig. 5a–c and Fig. S5). We presumed that the filamentous FN
structure is a multimeric FN, i.e., FN fibril. FN fibrils within the ECM play central roles in both physiological
and pathological processes during development and tissue regeneration by coordinating cell adhesion, growth,
migration and differentiation. FN is assembled to form FN fibrils in an integrin- and actin stress fiber-dependent
manner35–38. In vitro studies using fibroblasts and platelets have suggested that integrins and some agonists for G
protein–coupled receptors including LPA are involved in the assembly of FN fibrils39–41. The present results clearly
demonstrate that LPA1 signaling induced assembly of the filamentous FN structures undersurface of chondrocytes; the FN structures then modified the proliferative and adhesive property of the cells. The structures were
co-localized with actin stress fiber and β 1-integrin (Fig. 5a,b) and their formation was canceled by Y27632 and
PTX (Fig. 5a,c). The coordinated changes in integrins and the actin cytoskeleton observed here parallel cadherin
and focal adhesion assembly associated with actin changes observed in Schwann cells of the nervous system42. All
together, these findings support the idea that the filamentous FN structure is an FN fibril and that the LPA-LPA1
axis regulates actin stress fiber formation and then β 1-integrin translocation. These changes stimulate the FN
assembly to form FN fibrils, which enhances the proliferation of chondrocytes (Fig. 7). This model is further
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supported by the observation that the ECM formed by chondrocytes in the presence of LPA1 signaling supports
cell proliferation more efficiently than ECM formed in the absence of LPA1 signaling (Fig. 6b). The observation
also implicates that integrin activity itself can be regulated in both an inside-out and outside-in manner43,44. The
present results indicate that the ATX-LPA1 axis regulates integrins in an inside-out manner (from step (i) to (v)
in Fig. 7), which results in the formation of FN fibrils and the subsequent organization of other ECM components
such as Col II. The ECM thus formed then regulates integrins in an outside-in manner (from step (v) to (vi) in
Fig. 7), which contributes to proper cell adhesion and proliferation of chondrocytes, leading to normal cartilage
development. Thus, in addition to the previously indicated LPA1-Gαi-Akt pathway45, we propose a new model
of ATX-LPA-LPA1 axis-induced cell proliferation that is mediated by integrin-dependent fibronectin assembly,
occurring in an “inside-outside-in” manner (Fig. 7).
A key question is whether cells other than chondrocytes utilize this system for their proliferative activity.
Chondrocytes and fibroblasts are both derived from mesenchymal stem cells. LPA1 KO mice were resistant to
bleomycin-induced lung fibrosis46 and unilateral ureteral obstruction-induced renal fibrosis47. Thus it is possible
that LPA-LPA1 signaling upregulates proliferation of fibroblasts in a manner similar to what we propose in chondrocytes. In addition, because LPA1 and ATX are overexpressed in several cancers8,48,49, the enhanced proliferation of certain LPA1-positive cancer cells, such as glioblastoma cells50, may reflect a similar mechanism, which is
currently being examined.

Materials and Methods
Reagents.

Lysophospholipids including 1-oleoyl (18:1)-LPA and 1-myristoyl (14:0)-LPC were purchased
from Avanti Polar Lipids. Lysophospholipids were dried under nitrogen gas and dissolved in 0.1% fatty acid-free
bovine serum albumin (Sigma-Aldrich)-PBS using water bath sonication and stocked in − 20 °C. Y27632, ROCK
inhibitor, was purchased from Merck. Pertussis toxin was purchased from Wako Pure Chemicals, GRGDSP and
GRGESP were purchased from AnaSpec. Ki16425 was chemically synthesized as described previously51. ATX
inhibitor, ONO-8430506 was a generous gift from Ono pharmaceutical Co., Ltd52.

Zebrafish lines.

Zebrafish were maintained according to the Guidelines for Animal Experimentation
of Tohoku University and the protocol was approved by the Institutional Animal Care and Use Committee
at Tohoku University. Wild-type AB zebrafish were obtained from Zebrafish International Resource Center
(University of Oregon, Eugene, OR). The LPA1 mutant was generated by target-selected mutational inactivation
of genes (TILLING) according to standard methods53. Fish were maintained at 27–28 °C under a controlled 13.5 h
light/10.5 h dark cycle. Embryos were obtained from natural spawning and staged according to morphology. The
standard staging of zebrafish embryos is used and determined in hpf (hour post fertilization) or dpf (day post
fertilization) at 28 °C54.

Generation of col2a1:egfp transgenic lines.

To generate a col2a1:egfp transgenic line, the col2a1 promoter18 was introduced upstream of egfp using the Tol2kit system55. Briefly, the col2a1 promoter was introduced
into p5E-MCS vector, and then p5E-col2a1, pME-EGFP, p3E-polyA and pDestTol2pA2 were combined with LR
clonase II plus (Life Technologies). Twenty-five ng of the DNA plasmid was injected into the embryos at the 1-cell
stage to establish a col2a1:egfp transgenic line that selectively expresses EGFP in cartilage.

Microscopic Analysis.

Zebrafish larvae were anesthetized with 0.016% tricaine methanesulfonate solution (Sigma-Aldrich) and positioned in 3% methylcellulose (Sigma-Aldrich) on a slide glass. Images were captured with a Leica M80 stereomicroscope equipped with a Leica DFC425 digital camera (Leica Microsystems).
Col2a1:egfp transgenic fish larvae were positioned in 1.5% agarose (Sigma-Aldrich) on a glass-bottom well
(MatTek, MA) and imaged with a LSM 700 confocal laser-scanning microscope (Carl Zeiss).

Alcian blue staining. Zebrafish cartilage and bone were double stained with alcian blue and alizarin red as
described previously56. At 4 or 5 dpf, larvae were fixed with 4% PFA in PBS, rocked at room temperature for 2 h,
washed and dehydrated with 50% EtOH at room temperature for 10 min. After removing the EtOH, the larvae
were double stained with acid-free stain solution (0.02% alcian blue, 0.005% alizarin red, 150 mM MgCl2 in 70%
EtOH), rocked overnight at room temperature, washed with water, depigmented with bleaching solution (1.5%
H2O2 in 1% KOH), rocked at room temperature for 20 min, and cleared with successive changes of a solution of
glycerol and KOH. The lengths of Meckel’s and ceratohyal cartilages were measured with a Zeiss Axio Imager
(Carl Zeiss MicroImaging). Larvae with smaller or abnormally bent cartilage compared with control larvae were
classified as ‘malformed’ larvae.
Antisense morpholino injection. The morpholino (MO) sequences were:
LPA1 MO, 5′-TGGAGCACTTACCCAATACAATCAC-3′13;
ATX MO1 (MO1-enpp2), 5′-GGAGAATACCTGGGTCGAGACACCG-3′14;
ATX MO2 (MO2-enpp2), 5′-TTCTTTCAAAGTCCCTACCTTTGCA-3′14.
LPA1 (2.5 ng), ATX MO1 (0.3 ng) and ATX MO2 (3.2 ng) of each MOs were injected into the yolks of one- to
two-cell stage embryos.
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Ki16425 treatment for zebrafish embryos.

Embryos were treated with 120 μM of Ki16425 in the
embryo medium with 1% DMSO57 from 48 hpf. Embryo medium containing Ki16425 was replaced approximately every 24 hours.

Genotyping of lpa1 mutant.

The lpa1 mutation was genotyped by restriction fragment length polymorphism (RFLP) analysis. All the primers were designed by a web-based program, dCAPS Finder 2.058. The primer
sequences were:
LPA1-180, 5′-ACAAGAAGGCTAACGGTTAGCACGTG-3′;
LPA1-181, 5′-ACAAGAAGGCTAACGGTTAGCAGGTG-3′;
LPA1-182, 5′-CATGACGATAGACATGGTCCAGATGATG-3′.
In the 198-bp PCR products derived from the wild-type allele with LPA1-180 and LPA1-182, an ScrFI restriction site was introduced, and therefore the ScrFI treatment degraded the 198-bp PCR product from the wild-type
allele into a 174-bp fragment. The PCR products were cleaved with ScrFI and resolved on a 4% agarose gel.
Similarly, the 198-bp PCR products from the mutant alleles with LPA1-181 and LPA1-182, HphI restriction site
were introduced. The HphI restriction enzyme degrades the PCR product from mutant allele into a 163-bp DNA
fragment.

Whole mount in situ hybridization. Antisense RNA probes labeled with digoxigenin (DIG) for lpa1, atx,

slug, sox10 and sox9a were prepared with an RNA labeling kit (Roche Applied Science). Whole-mount in situ
hybridization was performed as previously described59.

Mice.

Mice were maintained according to the Guidelines for Animal Experimentation of Tohoku University
and the protocol was approved by the Institutional Animal Care and Use Committee at Tohoku University. The
LPA1 KO mice generated by Contos et al.6 were transferred and maintained on a mixed 129SvJ/C57BL/6J background. Experiments comparing LPA1 KO and HT mice used offspring of mice heterozygous for the LPA1 mutant
allele. The ATX conditional KO mice with two floxP alleles (ATXflox/flox) were generated by van Meeteren et al.60.
ATX heterozygous KO mice (ATX+/−) were generated by Tanaka et al.9. Mice with a floxP allele and ATX null
allele (ATXflox/−) were generated by crossing ATX+/− and ATXflox/flox mice.

Skeletal analysis. Plain radiographs were taken using a soft X-ray apparatus (LaTheta LCT-200,
Hitachi-Aloka). The size of the head and the lengths of the femur, tibia and humerus were determined with ORS
Visual (Nihon Binary) software. Whole-mount skeletal staining was conducted as described previously, with
slight modifications61. Briefly, mice were skinned, eviscerated and dehydrated in 95% (v/v) ethanol overnight.
Skeletons were stained with 0.3% (w/v) alcian blue (Sigma-Aldrich) for 24 hours, stained with 1.5% (w/v) alizarin
red (Wako) for 2 hours, treated with 1% (w/v) potassium hydrate and stored in glycerol/EtOH.
Isolation of primary mouse rib chondrocytes.

Chondrocytes were isolated as previously described62.
In short, chondrocytes from rib were isolated from newborn wt, LPA1 HT or KO mice. Rib cages were dissected,
rinsed in PBS, incubated at 37 °C for 45 min in 3 mg/ml collagenase type II (Worthington), cleaned of adherent tissues and digested with 0.5 mg/ml collagenase type II at 37 °C overnight. The cell suspension was filtered
through a 40 μm cell strainer. The cells were washed, counted and plated. For all experiments, chondrocytes were
plated 48 hr before any treatment.

Evaluation of cell proliferation. Cell proliferation was determined with a Cell Counting Kit-8 (Dojindo).

Cells were plated in 96-well plates at 1 ×  104 cells per well and cultured in the growth medium. Sixty min before
the indicated time points, CCK-8 solution was added to each well and the cell numbers were measured by reading the absorbance (450 nm). To evaluate DNA synthesis, cells were seeded on cell culture-treated or Col II- or
FN-coated (Sigma Aldrich, 5 μg/mL each) wells in 96-well plates. After 24 hr starvation, the cells were treated
with 10 μM 5′-BrdU (Sigma-Aldrich) and 10% FCS or 10 μM LPA for the indicated times. When an inhibitor was
used, cells were treated with Ki16425 (5 μM), ONO-8430506 (10 μM), Y27632 (10 μM), GRGDSP (500 μM) or
GRGESP (500 μM) for 30 min before the addition of FCS or LPA. PTX (200 ng/mL) was treated at the same time
as starvation. 5′-BrdU incorporation was quantified by counting 5′-BrdU-positive cells. 5′-BrdU was detected
by anti-BrdU antibody conjugated to fluorescein (Roche, 1:1000). For EdU (Life Technologies) incorporation
in vitro, 10 μM EdU was used instead of 5′-BrdU. To examine the incorporation of EdU in vivo, pups (P0-1) were
subcutaneously injected with 50 mg/kg EdU and were sacrificed 2 hours after the injection. Heads of the embryos
were dissected and fixed in 4% paraformaldehyde overnight at 4 °C. Tissues were embedded in Optimal Cutting
Temperature (OCT) compound and stained according to the manufacturer’s instructions. EdU-positive cells were
counted in a resting zone within a unit area. All images were captured with the LSM700 confocal microscope
equipped with 10×/0.45 M27 Plan-Apochromat.

Tissue and cell staining. For histological analysis, newborn mice were fixed in 4% fresh paraformaldehyde
in PBS, pH 7.2, overnight, dehydrated in a graded alcohol series (50, 70, 90, 95, and 99.5%), and embedded in
paraffin. Sections were cut at 10 μm and stained with hematoxylin and eosin (Mutoh Industries).
For immunohistochemistry, paraformaldehyde-fixed tissues were embedded in OCT compound or in paraffin. For paraffin sections, antigens were retrieved with 10 mM citrate buffer (pH 7.0) at 120 °C for 10 min. Tissue
sections were cut with a cryostat (Leica Microsystems) or microtome (Leica Microsystems). Primary antibodies
were used with predetermined optimal concentrations. The primary antibody was anti-Col II (Abcam, ab21291,
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1:250). The secondary antibody to detect Col II was conjugated with Alexa Fluor 488 or 568 (Life Technologies,
1:200). Nuclei were counterstained with 4′, 6-diamidino-2-phenylindole (DAPI).
For Immunofluorescence, cells were plated on glass coverslips (Thermo Fisher Scientific) that had been treated
with cell culture or coated with Col II or FN, and were fixed with 4% paraformaldehyde in PBS for 30 min, permeabilized with 0.5% TritonX-100 in PBS for 15 min, and blocked with 3% BSA/PBS for 30 min. The primary antibodies were goat anti-FN (Santa Cruz Biotechnology, sc-6952, 1:50), rabbit anti-vinculin (Abcam, ab73412, 1:150)
and rat anti-β 1-integrin (Millipore, MAB1997, 1:1000). The secondary antibodies for detecting goat anti-FN,
rabbit anti-vinculin and rat anti-β 1-integrin were conjugated with Alexa Fluor 488 or 647 (Life Technologies.
1:1000). Actin filaments were stained with Alexa594-conjugated phalloidin (Life Technologies, A12381, 1:250).
Fluorescent images were captured with the LSM700 confocal microscope equipped with 63× /1.40 Oil DIC M27
Plan-Apochromat.

Time-lapse.

In live-cell imaging of chondrocytes, phase-contrast images were taken (LD plan-NEOFLUAR,
20x/0.4, Ph2, 6frames/hr) with a Zeiss inverted microscope (Axio Observer.Z1) equipped with a heated chamber
(37 °C) and CO2 controller (5.0%) over a period of 48 hr. Primary chondrocytes were seeded onto 12-well plates
(Greiner), incubated for 2 days at 37 °C and treated with an LPA1 antagonist (Ki16425, 5 μM) or an ATX inhibitor
(ONO-8430506, 10 μM). Live-cell images were taken every 5 or 10 min for 48 hr. We chased cells that divided
twice. The doubling time was taken as the time between the two divisions. The duration of the M phase was evaluated by cell morphology. Supplementary Videos 1–4 were simplified as 1.5 frames/hr for downsizing.

Evaluation of cell spreading.

Cells were plated on glass coverslips coated with Col II or FN and were
stained with phalloidin. Cell images were captured with the LSM700 confocal microscope equipped with
63×/1.40 Oil DIC M27 Plan-Apochromat. and the cell spreading areas were calculated using the Zeiss Efficient
Navigation system (Carl Zeiss).

Quantitative RT-PCR.

To prepare total RNA from tissues, tissues were first embedded in OCT compound and frozen sections were cut at 25 μm thickness and mounted on poly-l-lysin–coated LCM transfer film
(LEICA-BEST) on glass slides. The chondrocytes in the tissue sections were dissected with a Leica LMD7000
Laser Microdissection System. RNA of the harvested chondrocytes was extracted with an RNAqueous Micro
Kit (Ambion). Total RNA from cultured cells was isolated using a GenElute Mammalian Total RNA Miniprep
Kit (Sigma-Aldrich). Total RNA samples were reverse-transcribed using High-Capacity cDNA RT Kits (Applied
Biosystems) according to the manufacturer’s instructions. PCR reactions were performed with SYBR Premix Ex
Taq (Takara Bio) on an ABI Prism 7300 thermocycler (Applied Biosystems). Standard plasmids ranging from 102
to 108 copies per well were used to quantify the absolute number of transcripts of cDNA samples. The numbers of
transcripts were normalized to the number of transcripts of a house-keeping gene (GAPDH) in the same sample.
The primers used to determine mouse gene expressions were:
mGAPDH 5′-AGGAGCGAGACCCCACTAAC-3′ and 5′-CGGAGATGATGACCCTTTTG-3′;
mLPA1 5′-AGGAGGAATCGGGACACCA-3′ and 5′-AGCACACATCCAGCAATAACAA -3′;
m L PA 2 5 ′ - T G C C G C T T G A C T G G AT G T- 3 ′ a n d 5 ′ - G C T C C T T G C C G C T G T TAT T- 3 ′ ;
mLPA3 5′-ACCAACGTCTTATCTCCACACAC-3′ and 5′-CAGCAGCAGAACCACCAGAC-3′;
mATX 5′-GGAGAATCACACTGGGTAGATGATG-3′ and 5′-ACGGAGGGCGGACAAAC-3′;
mFibronectin 5′-CAGAACCAGAGGAGGCACAAG-3′ and 5′-CAATGGCGTAATGGGAAACC-3′;
mCollagen type II 5′-AGAGGGGACTGAAGGGACAC-3′ and 5′-GCACCCTGATCTCCAGAAGG-3′.

Evaluation of Fibronectin assembly.

Cells were plated on Col II-coated glass coverslips and stimulated
with LPA after 24 hr starvation for 24 hr. To measure FN incorporation, 1 μg/ml Hilyte-488 FN (Cytoskeleton)
was added with LPA. After 12 hours, cells were fixed and stained. Cells were treated with Ki16425 (5 μM), Y27632
(10 μM), GRGDSP (500 μM) or GRGESP (500 μM) for 30 min before LPA stimulation. PTX (200 ng/mL) treatment was applied at the same time as starvation. Fluorescent images were captured with the LSM700 confocal
microscope equipped with 63×/1.40 Oil DIC M27 Plan-Apochromat.

Decellularization. Cells were plated in 24-well plates with glass coverslips or 96-well plates at 1 ×  105 cells
per well and cultured in the growth medium. After 10 days, cells were washed with PBS and treated with 0.5%
Triton X-100 and 20 mM ammonium hydroxide in PBS for 5 min. Decellularized ECMs were treated with DNase
(Sigma-Aldrich) at 50 unit/mL for 60 min at 37 °C, then gently washed with PBS. 24-well plates were stained with
anti-FN antibody and images were captured with a Leica TCS SP-8 confocal microscope. 96-well plates were
stored at − 80 °C until use. To assay cell proliferation, cells were plated onto decellularized ECM plates at 0.5 ×  104
cells per well.
Western blot analysis of deoxycholate (DOC)-insoluble fibronectin. After 10 days culture, cells
were washed with PBS and solubilized with deoxycholate lysis buffer (DOC-buffer) containing 2% sodium deoxycholate, protease inhibitors (Complete Protease Inhibitor Cocktail, Roche), 20 mM Tris-HCl pH 8.8, 2 mM EDTA,
2 mM iodoacetamide and 2 mM N-ethylmaleimide. Homogenates were passed ten times through a 23-gauge
needle, and centrifuged at 15,000 ×  g for 15 min at 4 °C. DOC-insoluble fractions were washed with DOC-buffer
3 times and then solubilized with SDS lysis buffer (1% SDS, 25 mM Tris-HCl pH 8.0, 2 mM EDTA, protease
inhibitors, 2 mM iodoacetamide and 2 mM N-ethylmaleimide). Equal volumes of DOC-insoluble samples were
analyzed by SDS-PAGE using 5% polyacrylamide gels. The primary antibody was goat anti-FN (Santa Cruz
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Biotechnology, sc-6952, 1:200). A secondary antibody conjugated with horse radish peroxidase (Dako, P0449,
1:1000) against goat IgG was used. Images were captured with a digital gel imaging system (ChemiDoc XRS+,
BIO-RAD).

Evaluation of ECM amount. After decellularization, ECMs were solubilized with 5.0 M Urea, 2.0 M
Thiourea, 50 mM DTT and 0.1% SDS in PBS and scraped with a rubber policeman63. The collected lysates were
placed in 95 °C water for 5 min and centrifuged at 12000 ×  g for 10 min at 4 °C. Protein concentration was evaluated by the Bradford method.
Transmission electron microscopy (TEM). Samples were fixed with 2% paraformaldehyde and 2% glutaraldehyde in 0.1M cacodylate buffer pH 7.4 at 4 °C overnight, washed 3 times with 0.1 M cacodylate buffer for
30 min each, postfixed with 2% osmium tetroxide in 0.1M cacodylate buffer at 4 °C for 3hr, dehydrated in graded
ethanol solutions (50%, 70%, 90% and 100%), infiltrated with propylene oxide (PO) 2 times for 30 min each,
transferred to a 70:30 mixture of PO and resin (Quetol-812, Nisshin EM Co.) for 1h, allowed to stand overnight to
volatize the PO, transferred to fresh 100% resin and heated at 60 °C for 48 hr to polymerize the resin. Seventy-nm
sections were cut from the polymerized resins (Ultracut UCT, Leica), mounted on copper grids, stained with 2%
uranyl acetate at room temperature for 15 min, washed with distilled water, secondary-stained with lead stain
solution (Sigma-Aldrich) at room temperature for 3 min and observed with a transmission electron microscope
(JEM-1400Plus, JEOL) at an acceleration voltage of 80 kV.
In situ hybridization.

Heads from newborn mice were embedded in OCT compound. Seven-μm-thick
sections were cut, placed on MAS-coated glass slides (Matsunami Glass), fixed with 4% PFA-PBS, acetylated
with 0.5% (v/v) acetic anhydride/0.1M triethanolamine pH 8.0, permeabilized with 0.3% (v/v) TritonX-100/PBS,
hybridized with digoxigenin labeled-RNA probes corresponding to 4551-4988 nt of Col2a1 cDNA (NM031163)
or 1302-1816 nt of Col10a1 cDNA (NM009925), incubated with anti-digoxigenin antibody conjugated with alkaline phosphatase (Roche), stained with NBT/BCIP (BM purple AP, Roche Diagnostics) and photographed with a
Zeiss Axio Imager (Carl Zeiss MicroImaging).

Determination of lysophospholipase D activity. Lysophospholipase D activity of mice plasma was
determined as described using 14:0 lysophosphatidylcholine as substrate8.
Statistics. All statistical analyses were carried out using EXSAS. Differences were considered significant at
P <  0.05. All data are expressed as means ±  s.d.
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